B
Braidwell Portfolio holdings
AUM
$2.92B
1-Year Return
4.59%
This Quarter Return
+2.55%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.92B
AUM Growth
+$79.1M
(+2.8%)
Cap. Flow
-$855M
Cap. Flow
% of AUM
-29.25%
Top 10 Holdings %
Top 10 Hldgs %
45.84%
Holding
71
New
6
Increased
13
Reduced
17
Closed
13
Top Buys
| 1 |
CAI
Caris Life Sciences, Inc. Common Stock
CAI
|
$195M |
| 2 |
Krystal Biotech
KRYS
|
$45M |
| 3 |
Edgewise Therapeutics
EWTX
|
$36.1M |
| 4 |
Inspire Medical Systems
INSP
|
$28.5M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$28M |
Top Sells
| 1 |
Transmedics
TMDX
|
$80.4M |
| 2 |
iRhythm Technologies
IRTC
|
$39.5M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$38.9M |
| 4 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$28.2M |
| 5 |
Guardant Health
GH
|
$25.5M |
Sector Composition
| 1 | Healthcare | 71.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ironwood Pharmaceuticals
IRWD
$167M
| – | – |
-6,622,584
| Closed | -$9.74M |
|
52
Sarepta Therapeutics
SRPT
$1.9B
| – | – |
-234,500
| Closed | -$15M |
|
53
Trevi Therapeutics
TRVI
$867M
| – | – |
-72,083
| Closed | -$453K |
|
54
Skye Bioscience
SKYE
$108M
| – | – |
-825,732
| Closed | -$1.31M |
|
|
BCAX
55
Bicara Therapeutics Inc. Common Stock
BCAX
$636M
| – | – |
-2,162,803
| Closed | -$28.2M |
|
|
BBNX
56
Beta Bionics, Inc. Common Stock
BBNX
$868M
| – | – |
-140,000
| Closed | -$1.71M |
|
|
MTSR
57
Metsera, Inc. Common Stock
MTSR
$3.72B
| – | – |
-175,000
| Closed | -$4.76M |
|
|
AARD
58
Aardvark Therapeutics, Inc. Common Stock
AARD
$176M
| – | – |
-500,000
| Closed | -$3.76M |
|